Work

Supplementary Figure 2 from Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion

Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure 2. Survival ROC curve for TAA burden and Foundation One TMB for predicting patient alive two year after ICB treatment. Kaplan-Meier estimator is used to calculate the sensitivity and specificity for each marker in predicting patient alive at month 24 following ICB treatment based on overall survival data. The R package “survivalROC” is used for this analysis.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W7164997907
Cites:
Cited by:
Related to: 10